Friday 4/12 Insider Buying Report: SYRS, HY

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.

At Syros Pharmaceuticals, a filing with the SEC revealed that on Tuesday, Director Srinivas Akkaraju purchased 533,332 shares of SYRS, for a cost of $7.50 each, for a total investment of $4M. Bargain hunters are able to bag SYRS at a price even lower than Akkaraju did, with shares trading as low as $6.83 in trading on Friday — that's 8.9% under Akkaraju's purchase price. Syros Pharmaceuticals is trading up about 3.2% on the day Friday. This buy marks the first one filed by Akkaraju in the past twelve months.

And at Hyster-Yale Materials Handling, there was insider buying on Tuesday, by Victoire G. Rankin who bought 1,640 shares for a cost of $64.99 each, for a total investment of $106,583. Before this latest buy, Rankin bought HY on 88 other occasions during the past twelve months, for a total cost of $10.41M at an average of $62.20 per share. Hyster-Yale Materials Handling is trading up about 1% on the day Friday. So far Rankin is in the green, up about 3.6% on their purchase based on today's trading high of $67.33.

VIDEO: Friday 4/12 Insider Buying Report: SYRS, HY

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Investing Videos

    The Basics of Estate Planning

    Investopedia Editor-in-Chief Caleb Silver joins Jill Malandrino on Nasdaq #TradeTalks to discuss the basics of Estate Planning. #NationalFinancialPlanning Month

    1 day ago is a one-stop source for aggregated data on dividend stocks, including features such as a dividend stock screener, a live dividend feed, an ex-div calendar, and a dividend calculator.

    Learn More